Northwestern Mutual Wealth Management
KYMR icon

Northwestern Mutual Wealth Management’s Kymera Therapeutics KYMR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.47K Hold
39
– – ﹤0.01% 3419
2026
Q1 		$3.25K Buy
39
+11
+39% +$871 ﹤0.01% 3449
2025
Q4 		$2.18K Buy
+28
New +$1.89K ﹤0.01% 3460
2023
Q3 		– Sell
-150
Closed -$3.45K – 3433
2023
Q2 		$3.45K Buy
150
+145
+2,900% +$4.16K ﹤0.01% 2879
2023
Q1 		$148 Buy
+5
New +$161 ﹤0.01% 3219

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Northwestern Mutual Wealth Management's KYMR Position: Q2 2026 in Review

Northwestern Mutual Wealth Management held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 39 shares worth $4.47K. The position accounts for ﹤0.01% of the portfolio, ranked #3419.

Northwestern Mutual Wealth Management first reported a position in KYMR in Q1 2023 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Northwestern Mutual Wealth Management held 39 shares of Kymera Therapeutics worth $4.47K as of Q2 2026.
  • Northwestern Mutual Wealth Management left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3419 holding.
  • Northwestern Mutual Wealth Management first reported a position in Kymera Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.